Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xueniao'an Capsules is a Traditional Chinese Medicine (TCM) developed and manufactured by Anhui Leiyunshang Pharmaceutical. It is approved in China for the treatment of hematuria (blood in the urine) and urinary strangury associated with 'damp-heat' in the lower burner, conditions typically manifesting as urinary tract infections (UTI) or bacterial cystitis. The formulation is composed of several botanical extracts, including Herba Cephalanoploris (Xiaoji), Nodus Nelumbinis Rhizomatis (Oujie), Pollen Typhae (Puhuang), and Radix et Rhizoma Notoginseng (Sanqi). These ingredients work synergistically to cool the blood, resolve stasis, clear heat, and promote diuresis, thereby addressing the underlying inflammatory and hemorrhagic symptoms of urinary tract disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xueniao'an capsules.